Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
一项随机 II 期研究旨在评估单药纳武利尤单抗在维持急性髓系白血病缓解中的作用。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015176
Pyzer, Athalia R; Dillon, Laura W; Sharon, Elad; Karrison, Theodore G; Zha, Yuanyuan; Fulton, Noreen; Gui, Gege; Andrew, Georgia; Streicher, Howard; Sweet, Kendra; Yaghmour, George; Liu, Jane Jijun; Jonas, Brian A; Schimmer, Aaron D; Grant, Steven; Zeidan, Amer M; Hildebrandt, Gerhard C; Lowrey, Christopher H; Mattison, Ryan J; Palmisiano, Neil; Salhotra, Amandeep; Tzachanis, Dimitrios; Baer, Maria R; Lin, Tara L; Patel, Prapti; Chen, Helen; Stadler, Walter M; Odenike, Olatoyosi; Larson, Richard A; Gajewski, Thomas F; Hourigan, Christopher S; Stock, Wendy; Liu, Hongtao
